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The proppwk of palkn’; aith nrdinmyapatby a.wciated 
atlh hypwamitimmis is uncertain. Cardiac homodynam- 
ica, hktobgk tiding8 and rspmse to oral vearnittno 
tberaw were re,rosDeeti*etY va,.a,ed in Ii ehlldre” with 
d@mm wm ST-T wwe inversion in the kft preardlal 
MI wttk vsrbw de,yea of kft rentrktdar hyprtmphy. 
Eeh0cardbgmphkatty, ,wo palklltl wttll ,lypww@phic 
wdtc.myop*hy hd drereased tet, vm,rteuter fundton 
Cardiac muscle is capable of utilizing either free laity acids 
derivatives (2). provide for the prepondcrancc of whctratc. 
Camitine (3.hydmxy-4.N-trime,hylaminobu,yric a id) is an 
imwrbml amine that lraworts lone. chain fatty acids from 
the cytoplasm XKISE lhe~inner milochondriai membrane 
where beta-oxidation proceeds II-It. Since camitine defi- 
ciency in humans war’firr, repwled by Engel and Angelini 
(4) in 1973. more than 30 cases have been reponed and 
classified as myopathic or syslemic. according ,o ,issue 
camitine distributions t5-18). Myopathic forms were char- 
acterized by normal plasma levels but low skeletal muscle 
e,bbpy kcaux L-amltiln r”ppkmen,&n may wad to 
improvement. 
(I Ant CO,, cerdio, 1!w;,,:noL8, 
cunccntrdlions of carnitine with progressive muscle weak- 
nesr: \y<,em,c forms were characterized by tw plasma and 
liswe carmtme concentrations wnh mut,iryr,en; invdve- 
mem. Somcrcportstt9~~ugge~,ed,ha,,bese,wufirrmswere 
due ,o differen, enzyme defects. Hypoearnitinemi~ may alru 
occur with some inborn erron of metabdism such ar pro- 
pionyt-coenzyme A carboxytase deficiency. isovakric acide- 
mia or bomocylinuria l2nl 
Recently. i cardiomyoptby accompanied by congevlive 
hean hdure was described in patients wilh bocb forms of 
carnitine deficiency (5.6.9-15). We have faunc. however, 
,bal the clinical manifestation may be protean tn patients 
wth a carniline-related abnormality. This rt oospecdve 
study reviews the clinical manifeslatians, non’nvasive and 
invasive uardiac hemodynamics. cardisc bistolr~ic 6diegs 
and clintcal responses ,o oral L-camitine lherapy in a cohar, 
of such oa,icm<. 
S,udy pn,ipn~ tT#e I). From the metabolic data bare ;If 
The Hospital for Sick Children. Toronto. I I patienlr were 
identified who were seen betaeen January 1977 and August 
1986 with cardiomyopathy associated with abnormalities of 
camltins or fat melabolism. The plasma free camitine levels 
were lower than nonnal in all patients (mean concentmtion 
17.8 + 5.6 ~ollliter [normal control 32 to 53 ~molililer 1). 
The total plasma camitioe was 57.5 2 19.7 ,uxolflirer 
(normzd control M to Sn ,u,,o#iter,. The normn, va,,,e~ used 
in our laboratory are derived from published data (12.21.22). 
beca~a no slat~~lical dilre!ce e&s bePwen the values 
from !em~ newborn infants and those of older children (IQ, 
the data were applied as P single group. 
rhc pmienrs WIY clmsifird inrofmr subgroups based on 
the eliofogy of the hypocarniriwmia: Group A conriswd of 
three pall~nts (Patients 1.2.3) wilh enzyme defects of fatty 
acids oxidation manifested by mulliple acyl CoA debydro- 
genase. medium chain fatty acid and long chain fatly acid 
deficiency, respectively (3). GrOUQ B consisled of two Q% 
tienv (Patients 4 and 5) with Barth ryndrone (23). charac- 
terized bv hywcarnitinemia. dila:d csrdiomvooatbv. neu- 
tropenia and a skeletal myopathy. Group 6 &i&d of 
three patients (Patients 6,7,8) with a transidnl hypocamiti- 
wmia in the neonatal period. Tbe three patients in group D 
(P>.lients 9,lO.l I) had a low level of plasma-free camifioe: 
howvever. no specific enzyme defect has yat been idsntitird. 
Cl!nkal aad bemodyonmie valu&on. The &x&as’ his- 
low were reviewed with attendon to family history and 
neuromuscular symptoms in the neonatal period. C&iac 
evnlualion included physical examination, standard 12 lead 
electmcnrdiogram (EC@. chest ro+xt~eenog;am nd two- 
dimensional echocardiography. Three patients underwent 
cardiac catheterization with left ventricular angiography. All 
patients had serial two.dimansionnI echocardiography (gew- 
lelt-Packard 201 A or Advanced Technology Laboratory 
Mark SW). M-mode echowdiograms of Ihe righl and left 
ventricles VCR obtained from the two-dimensional images 
and recorded on a alrip chart UT video recorder. Echccar. 
diopraphic measurements of cardiac performance consisted 
of diastolic aml systolk letl ventricular internal dimensions. 
ejection fmcrion, fractkmal shortening, left and right anal 
dimensions, end-diasfalic right ventricular internal dimen- 
sion. thickness of the ventricular sepbm, and leh ventricular 
posterior wall, each variable related to the age 041. Left and 
right ventricular measurements were made in the short axis 
of the mitral valve plane, with both leatlets Gible. 
Cardiomyoparhy was clarr&%d as hyperrrophic ~1, dilured 
on the basis c&the morphology and function of the ventricles 
(25). In the hypertrophic type there was ixreased ventricu- 
lar muscle mass. >2 SDS above oormrd. of the ventricular 
septum and free wall, associated with normal indexes of 
systolic function. In the dilated fwm. dilation of both ven- 
tricks and pux pump function were prerem. 
Htstoloyc nahmtka. Biopsy spurnens of rkele!al wur- 
cle. liver and heart were obtained in three patients .~nd 
autopsy specimen; available in another two for light and 
eleclron microscopy. 
Fiama nrnillnr mwumnenl. Carnitine measurements 
consisted of random as well as slarvation levels of plasma 
camitine zmd its fractions (free. esterified and tolaO before 
and during L-carnitine therapy. 
Cunlllr treatmml. In eight patients. L-camitine. IWia 
250 mg orally. three or four times a day. was given for an 
avemge of : 7 i 0.8 yews (range 1 months tr) 2 years). Four 
patients lrceived diroxin and a diuretic and three received 
followne furmrr. alone or h combharion: II iwreax in 
cardmthoracic ratio of >5% on chest roenrgenogram; ?I
impmvemcnt of v&age and ST-T wave change on ECO: aml 
31 increase in ejection fraction of >5% on echocardiogram. 
Rt?S&tltY 
Of the I I patients reviewed. 6 had hypertmphic and 5 
dilated cardiomyopathy. Six patients b we male ImateKe- 
male ratio 1.2: I). 
Clinical cm (T&k I). Nine patients hd a 
history of congertire h&failure. Neurol& examiraion 
revealed hypotonia in seven and spa&city in one p&em. A 
hioory of hygogJycemis w seizures was present in three and 
four palientr. respectively. 
CbM roengmogrwn. The cardiothoracic ratio was 
XMO in eight patients. Four patients had pulmonary coo- 
g&on. No specific cardiac con@oration was seen. 
Elearowvtliognm ITabk 21. The roost frequent ECG 
abnarmrlities ~‘ere tachvcardia. T wave abnorroalitier IFit!. 
II wli~ :nverzion in leads V, to V, in four oatients and 
diffascly low roltace in three palientr. Signs of IelI or rieht 
ve”r”c”lx hyper,;phy were common. 
Eehocwdiiphy (Table 2). Two-dimensional and M- 
mode echocardiography revealed an increased left ventricu- 
lar diastolic inlemal dimension in !hree and increaeG right 
venrrular in!emzl dimension in four patienls (Fip ?I. Two 
palienla with hypenrrphic cardiomyopalhy (Palienlr 3 and 
6) had decreaced ejection and shorlening fractions with 
oomml diasolic Icfr ventncular dimension. Six of the I! 
palient~ had increased thickness of the ventricular scplom 
and pare&x uall (Fig. 3). The ventricwlar rephmJporterior 
wll rario was > 1.3 in four palients. No patient had sys~olk 
anlrrior molion of the rnilrdl Met. 
Cardii calhtlerizatlrm mod angiogmpby. Car:linc cathe- 
leri7alion war performed in one parienl wilh hypenrvhic 
(Paricnr 10) and two padents with dilated cardiomyopathy 
lPalients 4 and 9). Left ventricular systolic and end-diastolic 
and aorlic systolic pressures were normal in all. Patient 9 
had B lefr to riahl alrial shunt of 1.8:l. Patient IO had an 
clevaled r&h, &,ricuior sysrolic pressure level (44 mm “g) 
and a peak systolic gradient of 26 mm Hg across the righr 
venlricular outflow tract. Cardiac index was normal in all. 
Left ventriculography in Patients 4 and 9 revealed enlarge- 
ment and pow contmclility of the lefl ventricie with an 
ejection fraction of 31 and S4%, respeclively. 
Histdogie evshmtion. Light microscopy obtained fmm an 
endomy&dial biopsy (Patient 10) re&ed focal myocyte 
hypatrophy with prominent nuclei. Electron microscopy 
revealed minimal lipid vacuolation. The liver and skeletal 
muscle specimens showed moderate amounts Of lipid wu- 
mulation. the contents of the vacuoles identified as :~eulral 
rats. 
Ar urtrruw (P&-nrs I nnd 31. moms and nicmscooic 
muhisyste~ iatty changer involving-liver, myacardial dd 
skeletal muscle and renal tubuler were found. The ventricu- 
lar chambers were hypertmpbied and mildly dilated. Micros- 
copy Of Ihe myocnrdium revealed focal necrosis with con- 
traction hands and a modemtc degree of diffuse fattv chance 
(Fig. *a). Elsc!ros microscopic &snination revs&d strik- 
ing lipid deposits in the cytoplasm (Fig. Jb) with severe 
myufibril disruption. Abnarmai awzptcd mitochondria 
were PbO teen in Patient t. 
Clinkat outeonx after avniline treatment. Six of engbt 
patients on carnitine suoolementation lmoroved clinicallv 
&ring the 3 months to i &WS of follow-& (Table 31. Oni 
(Patienl 3) died of ventricular !xhycardia. The cardiotbo- 
ractc ratto decreased significanrly after uetnm~nt in five 
patients. In four, the ECG showed improvement i- ST-T 
waves but persistace of mild left ventricuhr hypertropby 
!Fig. I). Echocardiogmphic irnpnwemcnt in ejection and 
shortening fractions and venlricular chamber size occurred 
in six of et&!: paiieets wthoul slgniiicant reduclion in 
pasteri~r wall thickness. Digoxin and diuretics bad been 
administered m four (Rxients 4. 5. 6 and 9) of these six 
patkilts. 
Figure 0. Patient I. P. Light microscopic section of the left venlri- 
cdsr myocardwn showing mywyts vacuolizaation due 10 fatly 
change. b, Elect”,” micmscnpic JCC~:GD ,howin~ cytoptacmic lipid 
dep+xit~ adjacent to the nuclew and mitccb~ndria. 
Discussion 
Cwdiomyopathy in camitine defictwctes. C&tine is 
synthesized from lysine and methionine in the liver and 
kidney and is present in tht, diet (3). The healt is unable to 
synthesize camidne and therefore its concentration depends 
on intake from diet or retewe from liver and kidney, or both. 
Camitine participates in the transpu* of activated fat y acids 
(Acyl-CoAl across inner mitwzhondrial membrane in mya- 
cardium as wcil a~ skcletai muscle and liver (l-3). The lack 
of camitinc, whether primary or secondary, results in dis- 
turbed transpon of long chain fatty acids into the mitochon- 
dria and results in myocardiat dysfunction by lipid accumu- 
lation and dependence on anaerobic metabolism (ptucose) 
forenwzv. In auto~sv cases offatal camitine deticiencv with 
cardiomyopathy. extensive vacuolization was found in mya- 
cardial fibers. In this rcprd, Tripp et al. (I41 repurted a 
severe form of familial dilated cardiomyopathy similar to 
endocardial fibroelastosis due to systemic camitine deti- 
ciency. The histologic evaluaion at autopsy revealed mar- 
sive lipid accumulation with endocardial tibrosi\ in both 
ventricles. In two of our patients (Pa!ients I and 3). his- 
tologic findings revealed similar lipid accumulation and 
hypertrophy of myocytcs; however. endocardial fibrculast- 
osis was not present. 
Recently, Baflh et al. (23) described an X-linked reces- 
sive mitochondrial disease with dilated cardiomyopathy. 
r.sPtropenia and skeletal mvomthv. In their reoon. a&ted 
patient\ had low plawa &i m&le camitinc concentw- 
tioni. Our Padcntb 4 and 5 were clinically similar to those 
repaned by Barth et al.. with normalization of their cardiac 
function with L-camitine replacement. suggesting that hypo- 
camitinemin rnnay contribute to the pathogencsis of cardiac 
dysfunclion in this syndrome 
To our knowledge. cardiomyopathy caused by transient 
hypocarnitinemia in the newborn period, as seen in our 
Patients 6, 7 and 8. had not previously been reported. 
Newborns and early infants arc incapable of syntl&ing 
camitine (3) and depend on exogenous supplies. Wiihout 
exogenous carnitine fmm milk pmducts, symptoms of car- 
nitine deficiency may OECUI. We noted that the cardiac 
abnormalities in these newborn infants were present at birth, 
suggesting that the hypocamitinemia may have existed in 
fetal life and may represent a more extensive metabolic 
abnormality related to in utcm transport. 
Compwtwm with previous reports of famitlne defwkncy 
cardiomyopathy. Table 4 reviews previous reports of;?&- 
tine deficiency with cardiomyopathy (5,9,13-15.21.27). The 
male/female ratio was 2.3~1; the age at diagnosis ranged from 
II months to 8 years and was made at autopsy in three 
patients (14) and by echocardiography 01 wdiic angiogra- 
phy in seven patients. The type of cardiomyopathy was 
classified as dilated in 8 of the 10 EBSCS, including 4 in which 
findings were similar to those of endocardiat tibmelastosis; 
in the remaining 2 eases, hypertrophic cardiomyopathy was 
present. However. four patknts with dilated cardiamyo- 
pathy had an increased thickness of the ventricular septum 
OF left ventricular posterior wall, or both, and two patients 
with hypertrophic cardiomyopathy had a dccrcased ejec!ion 
fraction. In our patients, echocardiographic evaluation i n- 
onstmted that both hypcrtmphic and dilated cardiomyw 
pathy may exist in hypocamitinemia. Moreover, two pa- 
tient: with hypcrtrophic and two patients with dilated 
cardiomyopathy had both hypatrophy and poor contractil- 
ity of the left venlricle similar :o hemodynamic chamcteris- 
lies of the contracted form of cndocardial fibroelastosis (28). 
Weber et al. (ISI emphasized that the mmt wiking 
finding on the ECG was an extremely tall peaked T wave in 
the mid-prccardial leads. We did not observe this in our 
study group. Six of the II patiems had leR vemricular 
hyperirophy with invcne: T -waves in the left precordial 
leads, a finding not specific for cardiomyopathy with ahnor- 
mal camiiine metabolism. 
Resultsof~mitinc therapy. Ihe cardiac response 10 oral 
r-camitine treatment in patients with cardiomyopathy asso- 
ciated with camitine deficiency is comroversial. Impmve- 
mat in cardii systolic function was apparent in six of the 
eight patients given camitine suppler&ta,ion: however, 
four of these six patients had simultaneous inulropic support 
(digoxin). It is diEcult 10 conclusively demonstrate r&m. 
v%tively whether the improvement in function was due 
exclusively to camitioe supplementation. Moreover. cami- 
tine treatmen, did no, lead to regressiro of hypenmphy in 
the ventricular wall. suggesting that the myocyte lipid pool 
may be metabolically inactive. Further pmspective investi- 
gdtions are required to clarify these etfects. 
AwJciiskektal myopathy. Previous studies have dem- 
onstraled functional and microscopic abnormabues of skel- 
the cardiomy&thy is B manifes&on ;f aUgene&ed 
myopathy (26.28). In this regard. several investigators (~9) 
described patients with skeletal muscle weakness and abnor- 
mal electron microscopic findiws (increased lipid and abnor- 
mal mitochondria) v&o were f&d lo bar: a deficiency of 
plasma free cadline. and Dunnigan et al. (29) recently 
studied patients with cardiomyopathy who were found ,o 
have a reduction in skeletal muscle long chain acylcamitinc 
with normal plasma levels. Abnormal muscle weakness with 
an associated cardiomyopathy may give a clue ‘o the diag- 
nosis of a generalized myopathy with hypocamitinemia. 
Comlusioas. Both dilated ad hypertrophic cardiomyo- 
pathy can result from abnormal crrnitinc or fat metabolism 
The determination of plasma camitine concemradon shuuld 
p!ay an imponan, role in assessmen, of aU patients with 
either form of cardiomyopathy of uaknown origin bccausc 
cami,ine su;~+-~n~inn may lead to improvement despite 
the diverse metabolic derangements that have hypocamiti- 
nemia in common. Further inveslieation into these various 
abnormalities of o*idadve metabolism is required 10 be,,er 
understand the role of camitine and the cause of these 
mystifying types of cardiomyopathy. 
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